ABT
Abbott Laboratories · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -5.0% ·
share flow -1.6% ·
net new positions -5.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 182 | 0 | 1.10B | $99.82B | +5 | −4 |
| Q1 2026 | 184 | +3 | 1.11B | $114.25B | +7 | −5 |
| Q4 2025 | 180 | +2 | 1.17B | $146.24B | +3 | — |
| Q3 2025 | 24 | 0 | 623.34M | $83.47B | +1 | −2 |
| Q2 2025 | 22 | 0 | 527.92M | $71.78B | +1 | −1 |
| Q1 2025 | 19 | 0 | 196.20M | $26.01B | +1 | −1 |
| Q4 2024 | 19 | -1 | 182.48M | $20.63B | — | −1 |
| Q3 2024 | 19 | 0 | 108.33M | $12.33B | +1 | −1 |
| Q2 2024 | 19 | — | 110.87M | $11.51B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 77.17M | — | $8.73B | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 35.67M | +2.2% | $4.02B | 0.3% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 35.67M | +2.2% | $4.02B | 0.3% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 26.39M | +2.2% | $2.99B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (passive) | 20.98M | +3.5% | $2.37B | 0.3% | ▲ Add | 3 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 11.28M | +1.6% | $1.28B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 3.80M | -6.3% | $429.29M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 3.80M | -6.3% | $429.29M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.49M | +12.5% | $169.00M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 1.49M | +12.5% | $169.00M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 1.49M | +12.5% | $169.00M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 1.49M | +12.5% | $169.00M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 1.49M | +12.5% | $169.00M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 21 | Capital World Investors ✦ | 1.34M | +0.1% | $151.41M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 1.15M | -22.8% | $130.15M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 903.00K | +149.6% | $102.14M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 24 | PRIMECAP Management ✦ | 898.15K | -2.3% | $101.59M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 25 | Millennium Management ✦ | 572.11K | -55.1% | $64.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 305.35K | -84.2% | $34.54M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 27 | Arrowstreet Capital ✦ | 230.13K | -90.9% | $26.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Bridgewater Associates ✦ | 191.73K | -72.9% | $21.69M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 29 | Gotham Asset Management ✦ | 39.34K | -2.4% | $4.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 29.06K | -69.9% | $3.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 29.06K | -69.9% | $3.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 32 | GAMCO Investors ✦ | 22.23K | -1.5% | $2.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 33 | Dodge & Cox ✦ | 17.86K | 0.0% | $2.02M | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $14.05M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3,058 holders, 1.35B shares, $133.47B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 5.85K sh · $642,506
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology